|
Contact Mary Bryant, RiskWorld
staff, e-mail bryant@tec-com.com.
|
|
|
|
Access Excellence
|
|
Access Excellence is a national educational program that provides high
school biology and life science teachers access to their colleagues,
scientists, and critical sources of new scientific information via the World
Wide Web. A brief history of biotech discoveries which continue to influence
the field today, called Biotech
Chronicles, is included at this site. Essays on genetics and DNA
research, profiles of some of the influential individuals who have helped
build the biotechnology industry, and an integrated series of time lines
which provide an overview of biotechnology from a historical perspective are
included in the Biotech Chronicles. (Posted September
2000.)
|
|
http://www.accessexcellence.org/
|
|
|
|
Agricultural
Biotechnology
|
|
The United States Department of Agriculture (USDA) is one of three Federal
Agencies, along with the Environmental Protection Agency (EPA) and the U.S.
Food and Drug Administration (FDA), primarily responsible for regulating
biotechnology in the United States. Products are regulated according to
their intended use, with some products being regulated under more than one
agency. (Posted October 2000.)
|
|
http://www.usda.gov/agencies/biotech/
|
|
|
|
AGROGENE
|
|
AGROGENE is a leader in plant biotechnology. The
company's biotechnological expertise includes plant and animal breeding;
fingerprinting and protection; genetic resources; industrial uses of plants;
genetics; traceability and quality control; and GMO detection and
quantification. (Posted October 2000.)
|
|
http://www.agrogene.com/
|
|
|
|
APSnet - Plant Pathology On-Line
|
The international scientific organization American Phytopathological Society
has been devoted to the study of plant diseases and their control since its
founding in 1908. The society's members promote knowledge of plant diseases and
their control through publications, meetings, symposia, workshops and special
activities, as well as this web site. (Posted October 1999.)
|
|
http://www.scisoc.org/ |
|
|
|
Aurora Biosciences Corporation
|
|
Aurora Biosciences Corporation designs, develops and commercializes
proprietary drug discovery systems and technologies to accelerate and
enhance discovery of new medicines by the pharmaceutical and
biopharmaceutical industries. The Company is developing a proprietary
biology and high technology platform comprised of a portfolio of proprietary
functional genomics technologies, and a highly automated ultra-high
throughput screening system, known as the Company's UHTSS Platform. (Posted September
2000.)
|
|
http://www.aurorabio.com/
|
|
|
|
Australian Biotechnology Association
|
|
The Australian Biotechnology Association is a national body of companies and
individuals dedicated to the development and prosperity of the Australian
biotechnology industry. It is the peak body for the Australian Biotechnology
industry, and provides a ‘platform’ which brings together all the
relevant players involved in the Australian biosciences community. Its
mission is to facilitate the commercialisation of Australian bioscience in
the international marketplace. This website provides information about the
ABA, coming biotech events, and on-line access to a directory of Australian
biotech companies and organisations, the ABA’s journal "Australasian
Biotechnology" and the ABA series of educational leaflets. (Posted September
2000.)
|
|
http://www.aba.asn.au/
|
|
|
|
BioABACUS
|
|
Biotechnology Abreviation and Acronym Uncovering Service (BioABACUS) is a
searchable database of abbreviations and acronyms in Biotechnology that
contains terms in such categories as: Biochemistry, Cell Biology, Computers
and Internet, Diseases, Grants, Journals, Laboratories, Medicine, Molecular
Biology/Genetics, Neuroscience, Other Organizations, Professional Societies
and US Government. The data provided include the name of the term, its
meaning, the category in which it is mostly used and, when available, a link
in which additional information for the term can be found. (Posted
September 2000.)
|
|
http://www.nmsu.edu/~molbio/bioABACUShome.htm
|
|
|
|
BIOCODE
|
|
BIOCODE S.A. is a biotechnology company established in Liège, a city near
Brussels, the capital of the European Economic Community. It specializes in
the research, development, production and distribution of in vitro
diagnostic kits (IVD). The company produces poly- and monoclonal antibodies
in house and purifies proteins and peptides, runs immuno- and radioligand
receptor assays as well as enzyme immuno- and DNA probe assays. BIOCODE’s
policy is to systematically upgrade and diversify its technologies and
products in parallel with the progress of biotechnology and medicine.
(Posted October 2000.)
|
|
http://www.biocode.be/pages/main.htm
|
|
|
|
BIOCOM/san diego
|
|
BIOCOM/san diego is the regional association for biotechnology, medical
device and bio-agriculture companies in San Diego County. It includes a
significant service company sector, including finance, legal, architecture,
marketing, insurance and other companies specializing in business with the
life science industry. The company is actively engaged in ensuring that the
life science industry remains a strong and growing part of the region's
economy. BIOCOM proactively addresses significant business and legislative
issues, educates the general public, and develops programs to help these
companies operate efficiently and economically. (Posted
October 2000.)
|
|
http://www.biocom.org/
|
|
|
|
Biofind
|
|
Biofind is the Internet's "one-stop-shop" for world wide
Biotechnology industry information and news. (Posted
October 2000.)
|
|
http://www.biofind.com/
|
|
|
|
BioInformatics Services
(BIS)
|
|
BIS is a biotechnology firm specializing in applying the power of
computational biology to build solutions to
complex biological and data analysis problems faced by scientists in public
and private research institutes, biotechnology companies, and universities. (Posted
October 2000.)
|
|
http://www.bioinformaticsservices.com/
|
|
|
|
Biology and
Biotechnology Research Program at the Lawrence Livermore National Laboratory
|
|
The Biology and Biotechnology Research Program is focused on three strategic
thrust areas: genomics, disease susceptibility and prevention,
bioengineering research. These thrust areas provide a set of core
compentencies and a foundation for our laboratory-wide strategic plan in the
biosciences. (Posted
October 2000.)
|
|
http://www-bio.llnl.gov/bbrp/bbrp.homepage.html
|
|
|
|
BioMetics, Inc.
|
|
BioMetics, Inc. provides engineering, design, validation, cGMP consulting
and project management services for biopharmaceutical and environmental
technology companies. The company delivers the highest quality of services,
adding value to each project through innovative approaches to design and
cost containment. (Posted October 2000.)
|
|
http://www.biometicsma.com/
|
|
|
|
Bio Online
|
|
Bio Online is a comprehensive site for biotechnology-related information and
services. The site contains current news, featured articles, events,
industry reports and analyses, press releases, product information, and much
more. Bio Online exists to create a distributed on-line community of scientists, professionals, businesses and organizations supporting the
life sciences for the purpose of facilitating communications and disseminating
information within that community. Opening channels of information can only benefit those who strive to contribute to these endeavors.
(Posted September 2000.)
|
|
http://www.bio.com/os/start/home.html
|
|
|
|
BioSpace.com
|
|
A global hubsite for the life sciences, including current news, industry
events, resources, search tools, and much more, to help foster a worldwide
community of shared interests within the biotech industry. (Posted
September 2000.)
|
|
http://www.biospace.com/
|
|
|
|
BioTech's
Biotechnology Dictionary
|
|
A searchable online dictionary of biology, chemistry and biotechnology
terms. This free resource is still very much under construction. Currently,
most of the 8300+ terms deal with biochemistry, biotechnology, botany, cell
biology and genetics. There are also some terms relating to ecology,
limnology, pharmacology, toxicology and medicine. Don't expect to find
common or exotic animals here; there are far too many species to cover even
a fraction in a resource like this. However, medically- and
biotechnologically-relevant organisms such as bacteria, worms, fungi, and
some plants are included. Looking for a chemical acronym? Try searching BioTech's
Chemical Acronyms Database. (Posted September 2000.)
|
|
http://biotech.icmb.utexas.edu/search/dict-search.html
|
|
|
|
BIOTECanada
|
|
BIOTECanada is a national organization dedicated to promoting a better
understanding of biotechnology and the many ways it contributes to improving
the quality of life of all Canadians. BIOTECanada represents Canadian health
care, agricultural, food, research and other organizations that are involved
in biotechnology. (Posted September 2000.)
|
|
http://www.biotech.ca/
|
|
|
|
Biotech Medical Management Association (BMMA)
|
|
BMMA, a non-profit professional organization, establishes a forum for the
open exchange of ideas and information between the pharmaceutical
manufacturers and the health plan/payor community. The views of clinical
provider, employer, consumer, and government representative members provide
a balanced view on utilization management and therapeutic care standards.
The goal of BMMA is to encourage active membership to impact and guide the
future development of medical policy regarding new and evolving
pharmaceutical products. With over 50% of the national population impacted
by managed care and managed drug benefits, payors and providers are more
actively involved in the approval and reimbursement of current and newly
developed products. (Posted September 2000.)
|
|
http://www.bmma.org/
|
|
|
|
Bio-Technical
Resources
|
|
Bio-Technical Resources provides innovative solutions
for the development of biotechnology products and processes through contract
services in research and development, bioprocess scale-up, pilot scale
manufacturing, technology and economic assessments. (Posted
October 2000.)
|
|
http://www.biotechresources.com/
|
|
|
|
Biotechnology and Biological Sciences
Research Council (BBSRC)
|
|
The BBSRC is the leading funding agency for academic research and training
in the biosciences at universities and institutes throughout the UK. The
research that funded aims to improve the understanding of living organisms
and biological systems in seven major areas: agri-food, animal sciences,
biochemistry and cell biology, biomolecular sciences, engineering and
biological systems, genes and developmental biology, and plant and microbial
sciences.
(Posted
October 2000.)
|
|
http://www.bbsrc.ac.uk/
|
|
|
|
Biotechnology Group of Danish Institute
of Agricultural Sciences
|
|
Biotechnology Group of Danish Institute of Agricultural Sciences, DIAS, is a
small research team engaged in plant breeding related research. Promoting
the use of transgenic crop plants in agriculture is at the core of all
research activities of the group. All projects comprise a mix of applied and
fundamental science, and the Group is thus an important link between applied
oriented DIAS and the Danish universities.
(Posted
October 2000.)
|
|
http://www.dias.kvl.dk/
|
|
|
|
Biotechnology Industry Organization
|
This international trade
association, also known as BIO, represents companies, academic institutions, and state biotechnology centers. Its members are involved in the research and development of health care, agricultural, industrial, and environmental biotechnology products.
BIO's web resources include a guide to biotechnology for editors and
reporters and information about biotech issues and policies regarding food
and agriculture, bioethics, and biotech drugs. (Posted May 2000.)
|
| http://www.bio.org/welcome.html |
|
|
|
Biotechnology Program at UC
Davis
|
|
UC Davis has long enjoyed a reputation as one of the world’s leading
institutions for research in biological sciences. UC Davis
houses leading departments in each of the major areas where biotechnology
has a significant impact: agriculture covering plant, animal, microbial
science, entomology and sustainability; medicine and veterinary medicine
including therapeutics, diagnostics and pathology; food science; bioprocess
technology and environmental science. Research in molecular and cellular
biology and biochemistry has led to the development of new research
approaches and the new tools of biotechnology. UC Davis views these recent
research results as part of a progressive cycle, with technology
contributing to the advancement of research goals and biological research
contributing, in turn, to the advancement of technology.
(Posted September 2000.)
|
|
http://www.biotech.ucdavis.edu/
|
|
|
|
BioTime, Inc.
|
|
BioTime, Inc. is engaged in the research and development of aqueous-based
synthetic solutions that may be used as plasma expanders, organ preservation
solutions, or solutions to replace blood volume during low temperature
surgery. (Posted October 2000.)
|
|
http://www.biotimeinc.com
|
|
|
|
BioValley
|
|
The principle goal of BioValley is the promotion of greater cooperation
between companies involved in the biotechnological and biomedical sectors
and the internationally respected scientific institutions associated with
universities in the BioValley area, most of which have already formed close
links between themselves. The intention is to address not only the many
pharmaceutical concerns already present in the BioValley area, but also to
involve the region's numerous smaller enterprises and suppliers. This calls
for the creation of a network strongly committed to technology transfer. (Posted
October 2000.)
|
|
http://www.biovalley.com/
|
|
|
|
BIRD Engineering
|
|
Biotechnology Integrated Research, Development
& Engineering (BIRD Engineering) specialises in contract research
and engineering in the areas of the fermentation technology and downstream
processing. BIRD Engineering was founded by the combined initiative of
researchers working in the field of bioprocess engineering, industrial
microbiology and biochemistry at Delft University of Technology and Applikon
Dependable Instruments, manufacturer of fermentation equipment and
analytical instruments. BIRD was originally set up to bridge the gap between
research at universities and industrial activities in biotechnology. The
company not only performs the necessary research but can also the
development and engineering studies with respect to industrial
biotechnological applications. In this way, BIRD comes up with solutions for
your problem that is not just an academic one but has also a practical
value. The main focuses are on those application areas which require a
combined know-how of bioprocess technology, microbiology, biochemistry and
genetics. In this central position BIRD is able to assist from the selection
of micro-organisms to scale-up of production processes. (Posted
October 2000.)
|
|
http://www.birdengineering.nl/
|
|
|
|
Boston Biomedica, Inc.
|
|
Boston Biomedica, Inc. is an infectious diseases management company
providing products and services for the detection and treatment of
infectious diseases (ID) such as AIDS, Lyme Disease, and Viral Hepatitis.
Boston Biomedica is also pursuing research and development programs in other
areas, including Pressure Cycling Technology (PCT), a new technology which
may allow more precise control chemical of reactions through the use of
pressure. (Posted October 2000.)
|
|
http://www.bbii.com/
|
|
|
|
Boston Life Sciences, Inc.
|
|
Boston Life Sciences, Inc., is a development stage biotechnology company
engaged in the research and development of novel therapeutic and diagnostic
products to treat chronic debilitating diseases such as cancer, central
nervous system disorders and autoimmune diseases. The Company currently has
11 technologies in its product portfolio, the majority of which were
invented or discovered by researchers working at Harvard and its affiliates
and have been licensed to the Company. (Posted October
2000.)
|
|
http://www.bostonlifesciences.com/
|
|
|
|
California Healthcare Institute
|
|
The mission of California Healthcare Institute is to (1) research, develop,
and advocate policies and actions that promote biomedical science,
biotechnology, pharmaceutical and medical device innovation in California;
(2) create a favorable environment for the State's biomedical and health
care technology community to discover, produce, and deliver products that
benefit society; (3)provide a forum to identify, analyze, and develop
positions on public policy issues that affect California's biomedical and
health care technology interest; (4) conduct research as a basis for
advocating responsible state and federal policies; (5) communicate to public
officials, providers, patients, and the general public the value of the
State's health care technology community for the health and economic
well-being of our nation's citizens and the economic growth of California;
and (6) identify and communicate the value of the products of health care
technology with regard to cost, benefit, and patients' quality of life. (Posted
October 2000.)
|
|
http://www.chi.org/
|
|
|
|
Cambridge Healthtech Institute
(CHI)
|
|
CHI services the biotechnical and biomedical markets by acting as an
information resource in an ever-changing environment. Through the
organization of scientific conferences and publication of market reports,
CHI offers a one-stop resource for learning about the latest technological
developments in such areas as genomics, drug discovery and development, lab
instrumentation, and blood products. CHI holds over 50 U.S. and
international events each year, and currently offer over 12 market reports
in its new Genomic Pathways Report Series. CHI events facilitate interaction
with key decision makers from leading pharmaceutical and biotech
organizations. This format offers companies who sponsor or exhibit at a CHI
event direct access to individuals who are interested in their products and
services. (Posted September 2000.)
|
|
http://www.healthtech.com/
|
|
|
|
Capralogics Inc.
|
|
Capralogics provides custom antibody services to the research community and
is a manufacturer of polyclonal antibodies against cell membrane receptors,
nuclear components, apoptosis factors, neuropeptides, oncoproteins,
signaling intermediates, transcription factors and proteins involved in
infectious diseases. The company offers a complete service package ranging
from protocol and peptide development through purification services.
(Posted October 2000.)
|
|
http://www.capralogics.com/
|
|
|
|
Cascade Biologics Inc.
|
|
Cascade Biologics is a supplier of cell culture and molecular biology
products. The scientists at Cascade Biologics are experts in the isolation
and propagation of numerous cell types from different tissues, and in the
development of specialized cell culture media for the growth of these cells.
(Posted October 2000.)
|
|
http://www.cascadebio.com/
|
|
|
|
CEDRA Corporation
|
|
CEDRA Corporation is a provider of excellence in biotechnical services for
the pharmaceutical industry and federal government. In addition to
analytical chemistry services, CEDRA also offers toxicology/pharmacology,
metabolic, synthetic chemistry, and pharmacokinetic/statistical services. (Posted
October 2000.)
|
|
http://www.cedracorp.com/
|
|
|
|
Cell Genesys Inc.
|
|
Cell Genesys is engaged primarily in the development and commercialization
of gene therapies to treat major, life-threatening diseases, including
cancer and AIDS. Cell Genesys currently has two gene therapy programs, the
clinical programs and the pre-clinical programs. The clinical programs
include GVAX(tm) cancer vaccines in Phase I/II studies to treat specific
types of cancer, such as lung and prostate cancers, and T cell gene therapy
for AIDS, which is undergoing Phase II testing. (Posted
October 2000.)
|
|
http://www.cellgenesys.com/
|
|
|
|
Cell Trends Inc.
|
|
Cell Trends Inc. is a biotechnology firm that offers technical and research
project work to scientists of virtually every level of sophistication:
industry, government agencies, medical schools, colleges, and universities.
Cell Trends offers a wide range of cell based laboratory services, utilizing
a diverse selection of mammalian and insect cell lines. Features include
baculovirus gene expression, DNA recombinant technology, soluble and
membrane bound protein production (using hollow fiber bioreactors, roller
bottles, or spinner flasks), gene cloning, transformant selection,
electrophoresis, PCR, ELISA, and selection of immortalized cell lines.
(Posted October 2000.)
|
|
http://www.celltrends.com/
|
|
|
|
Center for Advanced Biotechnology
and Medicine (CABM)
|
|
CABM was established in response to a recommendation in the report of the
Governor's Commission on Science and Technology that New Jersey should
create and maintain a world-class center in biotechnology. Launched in 1985,
CABM now encompasses the Core Facility, conducting basic research in the
areas of structural biology, molecular genetics, and cell and developmental
biology; and educational Programs, including lectures, seminars, symposia,
short courses, fellowships, and visiting scientist programs. (Posted
September 2000.)
|
|
http://www.cabm.rutgers.edu/
|
|
|
|
Center for Advanced Research in
Biotechnology (CARB)
|
|
CARB, located at the University of Maryland, was designed to meet the
specific needs of the biotechnology community in the field of protein
structure, function, and design. Scientists from the Biotechnology Division
of the Chemical Science and Technology Laboratory of NIST and the University
of Maryland have come together to conduct research programs in structural
and physical biochemistry and molecular biology. CARB, with sophisticated
state-of-the-art instrumentation, provides an exceptional environment for
training graduate students and postdoctoral fellows in fields critical to
the future of biotechnology. CARB offers a Visiting Scientists Program that
allows researchers from industrial, academic, and governmental laboratories
to work at the facility for extended periods. (Posted
September 2000.)
|
|
http://indigo15.carb.nist.gov/
|
|
|
|
Center for Biotechnology at Oak Ridge
National Laboratory
|
|
Biotechnology is an integrating science that emphasizes the development and
application of biological approaches, or the use of engineering and
computational capabilities, to meet national needs in health and
environmental protection, biomedical applications, environmental
remediation, pollution abatement, and energy production. ORNL is uniquely
positioned in this emerging field owing to its diversity of interactive
disciplinary foundations (e.g., biology, biochemistry, molecular biology,
computational sciences, chemistry, ecology, bioengineering, and biophysics)
and its core competency in biological and environmental science and
technology. The ORNL Center for Biotechnology provides a coordinated focus
for this biotechnology program, integrating activities across 14 ORNL
divisions and forming partnerships with other institutions, both public and
private, throughout the world. (Posted September 2000.)
|
|
http://www.ornl.gov/cbt/
|
|
|
|
ChemGen
|
|
ChemGen is a privately held biotechnology company specializing in developing
products through the use of microbial fermentation technology. The company's
focus has been on the production of enzymes for patented applications and on
chemicals, including pharmaceutical intermediates, using unique production
processes. (Posted October 2000.)
|
|
http://www.chemgen.com/
|
|
|
|
ChemGenes
Corporation
|
|
ChemGenes Corporation, a biotechnology company engaged
in the field of DNA/RNA synthesis. ChemGenes holds a number of patents in
the field of standard, modified, as well as backbone modified DNA/RNA
synthesis products. (Posted October 2000.)
|
|
http://www.chemgenes.com/
|
|
|
|
Cleveland
Biotech Ltd.
|
|
Cleveland Biotech grows and acclimatises
naturally occurring bacteria to create products for the degradation of
organic wastes, including fats, oil and greases, cellulose, petroleum
hydrocarbons, and chlorinated organics. Products are also available for the
degradation of inorganic pollutants such as ammonia and nitrite. (Posted
October 2000.)
|
|
http://www.clevebio.com/
|
|
|
|
Collateral Therapeutics
|
|
Collateral Therapeutics is focused on the discovery, development and
commercialization of non-surgical gene therapy products for the treatment of
cardiovascular diseases, including coronary artery disease, peripheral
vascular disease, congestive heart failure and heart attack. The Company's
non-surgical gene therapy product candidates include GENERX, GENEVX,
GENVASCOR, GENECOR, CORGENIC, and MYOCOR. These non-surgical gene therapy
products use technology, which includes methods of gene therapy, therapeutic
genes, and gene delivery vectors. (Posted October 2000.)
|
|
http://www.collateralthx.com/
|
|
|
|
Commonwealth Biotechnologies, Inc.
|
|
Commonwealth Biotechnologies provide sophisticated research and development
support services on a contract basis to the biotechnology industry. The
Company's customers consist of private companies, academic institutions and
government agencies, all of which use biological processes to develop
products for healthcare, agricultural and other purposes. The Company's
revenues are derived principally from providing macromolecular synthetic and
analytical services to researchers in the biotechnology industry or to
researchers who are engaged in life sciences research in government or
academic labs throughout the world. (Posted October 2000.)
|
|
http://www.cbi-biotech.com/
|
|
|
|
Compugen
|
|
Compugen is a pioneer in the fields of computational genomics and proteomics.
The company combines the disciplines of mathematics and computer science
with molecular biology to improve the understanding of genomics and
proteomics, the study of genes and proteins. Compugen's expertise in these
areas is used to develop core technologies and platforms that are the basis
for its products and services. These products and services are designed to
enable life scientists to significantly enhance their research efforts in
drug discovery, therapeutic and diagnostic. Compugen provides innovative
products and services to pharmaceutical, biotechnology and other life
science organizations through corporate solutions and to individual life
scientists. In addition, the company is commercializing the genes and
proteins that are discovered through the company's drug discovery division. (Posted
October 2000.)
|
|
http://www.compugen.co.il/
|
|
|
|
Conversations
about Plant Biotechnology |
|
Monsanto Company hosts this website that offers video discussions from
around the world with farmers and families who grow GM (genetically
modified) crops and experts who research and study the benefits of
agricultural biotechnology. (Posted
July 2008.)
|
|
http://www.monsanto.com/biotech-gmo/ |
|
|
|
Corixa Corporation
|
|
Corixa Corporation is a research and development-based biotechnology company
committed to treating and preventing autoimmune diseases, cancer and
infectious diseases by understanding and directing the immune system. The
Company is focused on immunotherapeutic products and has a broad technology
platform enabling both fully integrated vaccine design and the use of its
separate proprietary vaccine components (antigens, adjuvants or antigen
delivery technology) on a standalone, "Powered by Corixa" basis. (Posted
October 2000.)
|
|
http://www.corixa.com/
|
|
|
|
Council for Biotechnology Information
|
|
Leading biotechnology companies
have founded Council for Biotechnology Information to create a public dialogue
and to share information about biotechnology that is based on objective
scientific research, independent expert opinion, and peer-reviewed published
reports. The web site is also available in the French
language. (Posted May 2000.)
|
|
http://www.whybiotech.com/
|
|
|
|
Covance Inc.
|
|
Covance's biotechnology services include capabilities in cGMP manufacture of
monoclonal antibodies, growth factors, cytokines, and other recombinant
products for clinical trials and commercial use. The company offers a
comprehensive range of experience developing biopharmaceutical production
processes leading to optimal expression, purification, formulation, and
testing of recombinant products. Equally important, Covance can effectively
transfer established manufacturing processes into large-scale cGMP
manufacturing areas and provide a reliable supply of the highest quality
recombinant product. (Posted October 2000.)
|
|
http://www.covance.com/biotech/
|
|
|
|
CSL Limited
|
|
CSL Limited is an Australian public company specialising in the development,
manufacture and marketing of biologically based health care products which
benefit the community. Products include human and veterinary pharmaceuticals
(notably vaccines) and products derived from human plasma, diagnostics, and
cell culture reagents. CSL is firmly committed to research and development,
quality assurance and the development of international product and marketing
alliances. (Posted October 2000.)
|
|
http://www.csl.com.au/
|
|
|
|
CuraGen Corporation
|
|
CuraGen Corporation is an integrated, genomics-based drug discovery and
development company that is revolutionizing the Life Sciences industry by
merging biology with information technology. CuraGen has created an
integrated suite of genomics technologies to better understand the role of
genes in improving human health, animal health and agricultural vitality.
This technology is being applied to augment the discovery and development
efforts of the Company's collaborators, while simultaneously advancing the
development of CuraGen's internal pipeline of protein therapeutics and
antibody drugs for the treatment of complex diseases. (Posted
October 2000.)
|
|
http://www.curagen.com/
|
|
|
|
Dyadic International Inc.
|
|
Dyadic is a leader in the development and production of industrial enzymes
and speciality chemicals, holding US and International patents. Currently
the company's non-GMO products are used
in the textile, food, starch and animal feed industries. An area targeted
for future development is the pulp and paper industry. (Posted
October 2000.)
|
|
http://www.dyadic-group.com/
|
|
|
|
Dynal Biotech
|
|
Dynal Biotech, a company in Oslo, Norway,
developed Dynabeads, which are magnetic beads for efficient and quick
separation of cells, bacteria, proteins, subcellular compartments, mRNA and
DNA. This development has revolutionised the isolation and separation of
many biological materials. For instance, the attachment of target-specific
antibodies to the surface of the beads allows capture and isolation of
intact cells directly from a complex suspension, such as blood. This is all
accomplished under the influence of a simple magnetic field without the need
of column techniques or centrifugation. Dynabeads have been applied to three
major scientific areas: immunology, molecular biology, and microbiology. Dynal
Biotech is now taking involvement in cancer research areas, such as the
early detection of minimal residual cancer. In addition, the company
continues to enhance its competence in its core technology; particle
structure and surface chemistry, affinity ligands and immobilisation
strategies combined with the on-going development of dedicated products as a
solution provider in the biological and biomedical sciences. (Posted
October 2000, updated January 2001.)
|
|
http://www.dynalbiotech.com/
|
|
|
|
Enchira Biotechnology Corporation
|
|
Enchira Biotechnology is a leading-edge biotechnology company incorporating
genetic recombination and high throughput screening in an integrated,
directed evolution technology platform. This proprietary platform technology
can be used to generate libraries of novel genes for the creation of
improved gene-based products for a broad range of applications, such as
protein-based pharmaceuticals, agricultural crop enhancement and protection
products, and industrial enzymes for manufacture of specialty chemicals,
fine chemicals and pharmaceutical intermediates. The ability to generate
novel proteins with enhanced or altered properties has stimulated interest
in all areas of biotechnology, medicine, and the chemical sciences. (Posted
October 2000.)
|
|
http://www.enchira.com/
|
|
|
|
Enviro Research Pty
Ltd
|
|
Enviro Research has been engaged in microalgal culture research for a number
of years. The company has developed the world's first and only closed
photobioreactor which can be scaled up to any volume. The Envirocell offers
all the control, hygiene, efficiency and reliability of laboratory based
culture systems at industrial volumes. The Envirocell is currently the best
microalgal culture system in the world for the aquaculture industry, fine
chemicals/pharmaceuticals companies, health food/nutraceuticals industry,
and wastewater nutrients/toxins removal industry. (Posted
October 2000.)
|
|
http://www.enviro-research.com.au/
|
|
|
|
Epimmune Inc.
|
|
Epimmune develops therapeutic products for treatment of immunological
diseases. The company's core business is the development of vaccines to
treat and prevent infectious diseases and cancer. Epimmune's business also
includes a therapeutic anti-inflammatory program based on cell adhesion
inhibitors and its Glytec business unit, encompassing proprietary
manufacturing technology for the enzymatic synthesis of bioactive complex
carbohydrates. (Posted
October 2000.)
|
|
http://www.epimmune.com/start.html
|
|
|
|
European Federation of Biotechnology
|
|
The European Federation of Biotechnology is a voluntary association of
European non-profit-making scientific and technical societies active in the
field of biotechnology. The aim of the association is to enhance cooperation
between these societies in order to promote R&D in the multidisciplinary
field of biotechnology and to support its scientific, economic and applied
technical development in a socially and ethically acceptable manner. Also
see their Agri-Biotechnology Section.
(Posted September 2000.)
|
|
http://efbweb.org/
|
|
|
|
Exiqon A/S
|
|
Exiqon is a Danish biotech company focused on the development of enabling
technology platforms and novel DNA- and immuno-diagnostic products against
common genetic diseases, in particular, cardio-vascular, diabetic and other
chronic and degenerative diseases. In other fields Exiqon is a potential
technology partner for licensees. Exiqon's IPR includes LNA
(Locked Nucleic Acids) and a universal method for the covalent
coupling of diagnostic molecules to solid supports. (Posted
October 2000.)
|
|
http://www.exiqon.com/
|
|
|
|
Federal Bio-Technology
Transfer Directory
|
|
The Federal Bio-Technology Transfer Directory is an integrated information
resource designed for users in the biotechnology, pharmaceutical and
healthcare industries. Besides being essential for access to technology
transfer opportunities, the database is a unique source for competitive
intelligence concerning federal (and corporate) research, development and
commercialization activities. (Posted
October 2000.)
|
|
http://www.bioinfo.com/fbdinfo.html
|
|
|
|
Gemini Biotech
|
|
Gemini Biotech provides prompt, high quality, and cost-effective support for
research and drug discovery. The company's technical staff and consultants
are experts in synthetic chemistry and molecular biology. Gemini Biotech
specializes in custom DNA probes/primers, modified oligonucleotides and
DNA-RNA hybrids, full-length genes, gene sequencing, custom peptides and
modifications, peptide conjugates, and peptide antibodies. (Posted
October 2000.)
|
|
http://www.geminibio.com/
|
|
|
|
Genetics Forum
|
|
The Genetics Forum is an independent organisation in the UK concerned with
the use of new genetic technologies and their public policy implications. It
was founded by a group of scientists, lawyers and advocates from the animal
welfare, environmental and consumer movements concerned about the long-term
impact of rapid developments in the genetic sciences. (Posted September 2000.)
|
|
http://www.geneticsforum.org.uk/
|
|
|
|
Genetics
Institute
|
|
Genetics Institute is a leading biopharmaceutical company engaged in the
discovery, development and commercialization of human pharmaceuticals
through recombinant DNA and other technologies. The company has a
diversified portfolio of licensed and proprietary pharmaceutical products at
various stages of development, including treatments for anemia, hemophilia,
cancer, bone damage, inflammatory conditions and immune system disorders. (Posted
October 2000.)
|
|
http://www.genetics.com/genetics/genetics/index.htm
|
|
|
|
Genzyme Transgenics Corporation
|
|
Genzyme Transgenics Corporation, a biotechnology company, is a leader in the
production of therapeutic proteins in the milk of transgenic animals.
Transgenic animals carry specific genetic material that allows them to
produce human proteins in their milk. Unique molecular biology and
production expertise has enabled Genzyme Transgenics to produce more than 60
therapeutic proteins, including monoclonal antibodies, plasma proteins and
certain hard-to-express proteins in the milk of mice, rabbits, goats and
cows. The company has developed substantial expertise and increasing focus
on monoclonal antibodies for therapeutic use in chronic diseases such as
rheumatoid arthritis, other autoimmune conditions and cancer. (Posted
October 2000.)
|
|
http://www.transgenics.com/
|
|
|
|
Geron Corporation
|
|
Geron is a biopharmaceutical company that is focused on discovering,
developing and commercializing therapeutic and diagnostic products for
applications in oncology, drug discovery and regenerative medicine. Geron's
product development programs are based upon three patented, independent and
synergistic technologies: telomerase, human pluripotent stem cells, and
nuclear transfer. (Posted
October 2000.)
|
|
http://www.geron.com/
|
|
|
|
Greenpeace:
Genetic Engineering
|
|
This site, which is operated by Greenpeace, advocates no genetic
manipulation of nature. It focuses on (1) promoting natural foods and the
segregation of genetically engineered foods with proper labels, (2)
preventing genetically modified organisms from being released into the
environment, (3) preventing any living organisms or their genes being
subject to private property claims (i.e., no patents), and (4) promoting
genetic engineering issues being addressed by international bodies, with
international regulations based on the precautionary principle.
Greenpeace
USA, a part of the international
organization dedicated to protecting the health of planet Earth,
offers on-line
media kits providing background information on various issues,
including Greenpeace's concern that the FDA's safety standards regarding
genetically engineered foods are insufficient and may be putting human
health at risk. This media kit links to Greenpeace's report titled FDA
Approved: Genetically Engineered Soy and Corn in Baby Food and Nutritional
Supplements and to additional related information. (Posted September 2000.)
|
|
http://www.greenpeace.org/~geneng/gehome.htm
|
|
|
|
Igene Biotechnology
|
|
Igene Biotechnology focuses on the commercialization of value-added
specialty biochemical products for the food, feed, flavor and agrichemical
industries. Through the use of state-of-the-art fermentation technology,
physical and chemical separation technology, and related chemical and
biochemical engineering technologies, the company has developed proprietary
processes to convert selected agricultural raw materials or feedstock into
commercially useful and cost effective "environmentally friendly"
natural alternatives to products now produced by chemical synthesis.
(Posted October 2000.)
|
|
http://www.igene.com/
|
|
|
|
InfoBiotech Canada (IBC)
|
|
IBC is a partnership of government, private and academic sectors with the
goal of providing enhanced access to information on Biotechnology in Canada
and worldwide.
(Posted September 2000.)
|
|
http://www.cisti.nrc.ca/ibc/home.html
|
|
|
|
Information Systems for Biotechnology
(ISB)
|
|
ISB provides information resources to support the environmentally responsible use of agricultural biotechnology products. Here you will find documents and searchable databases
pertaining to the development, testing and regulatory review of genetically modified plants, animals and
microorganisms within the U.S. and abroad. (Posted
September 2000.)
|
|
http://www.nbiap.vt.edu/
|
|
|
|
Insect Biotech
Canada Inc. (IBC)
|
|
Insect Biotech Canada Inc. (IBC) is a Canadian-based, non-profit
biotechnology research and development consortium focused on the application
of biotechnology to insects and their pathogens. IBC has brought together
Canada's top researchers in insect physiology, biochemistry, insect virology
and molecular biology in an integrated and coordinated organization. The
network is focused on serving the needs of Canada and the international
community in identifying and controlling insect pests using current
techniques of biotechnology. (Posted
September 2000.)
|
|
http://www.zoo.utoronto.ca/insectbiotechcan/
|
|
|
|
Institute of Biosciences and
Bioengineering, Rice University
|
|
The Institute's mission is to promote cross-disciplinary research and
education encompassing the biological, chemical, and engineering
disciplines. The Institute represents a unique educational environment in
which to prepare students to meet the complex scientific, technological, and
ethical challenges they face as they head into the twenty-first century. (Posted
September 2000.)
|
|
http://ibb.rice.edu/
|
|
|
|
International Centre for Genetic
Engineering and Biotechnology
|
The International Centre for Genetic Engineering and Biotechnology
(ICGEB) was
established in 1987 by the United Nations Industrial Development Organization (UNIDO) to
promote the safe use of biotechnology world-wide and with special regard to the needs of
the developing world. In 1995 it became a fully autonomous international organization
composed of 41 member states. It has two main laboratories: one in Trieste, Italy, and one
in New Delhi, India. It also hosts a network of 27 Affiliated Centres, which are national
laboratories of member states. It sponsors both basic and applied research, including the
production of novel malaria and hepatitis vaccines, the study of human pathogenic viruses,
the study of human genetic diseases, and the genetic manipulation of plants. In 1995,
ICGEB and UNIDO created BINAS (Biosafety Information Network and Advisory Service) to monitor global developments in
regulatory issues in biotechnology. In 1998, the Centre added the ICGEB Biosafety WebPages, which are totally
dedicated to biosafety and risk assessment for the environmental release of genetically
modified organisms. Also in 1998, the Centre began publishing biosafety, a
bibliography of scientific articles on the main topics of concern about the environmental
release of genetically modified organisms. (Updated May 2000.)
|
| http://www.icgeb.trieste.it/icgebhom.htm |
|
|
|
InterSciences Inc.
|
|
InterSciences is a privately-owned and operated, scientific instrumentation
and supplies marketing organization representing specialized principal
manufacturers lines. InterScience's primary marketing focus is Biotechnology
for academic and hospital research, industrial, government, private lab and
Pharmaceutical segments of the Canadian market. (Posted
October 2000.)
|
|
http://www.interscience.com/
|
|
|
|
Iomai
Corporation
|
|
Iomai is a biopharmaceutical company
with products that greatly enhance human immune systems in the fight against
disease using its Transcutaneous Immuno Modulation (TIM) technology for
immunoprevention and immunotherapy. TIM works through the skin as a
non-invasive booster to the body's own immune system and can be targeted
against specific diseases. TIM products are administered easily and safely
-- painlessly stimulating the immune system to prevent or treat disease
through a skin patch, without needles or injections. The Company is focused
on rapid commercialization of the TIM technology through strategic
relationships with industry partners. The TIM project pipeline includes
products for three target markets: infectious diseases, cancer therapies and
autoimmune therapies. (Posted
October 2000.)
|
|
http://iomai.com/
|
|
|
|
Leinco
Technologies
|
|
Leinco Technologies is a global biosciences company
with manufacturing facilities. The company is built on a diverse
biotechnology platform and offers product development and contract
manufacturing services under GLSP and cGMP for active biopharmaceutical
intermediates. The company also offers an extensive line of antibodies,
recombinant proteins and reagents for research in immunology, cell biology,
and neuroscience. (Posted
October 2000.)
|
|
http://www.leinco.com/
|
|
|
|
Link Technologies Ltd
|
|
Link Technologies Ltd, established in Glasgow in 1989, is a
growing biotechnology company that now operates at the Strathclyde Business
Park. The company, which has a strong reputation in the U.S. and European
markets for manufacturing quality chemical reagents for the synthesis and
modification of DNA and RNA, is now also developing innovative reagents for
use in related areas of molecular biology, such as the structural study of
proteins and the synthesis of oligonucleotide-peptide conjugates. In tandem
with its expanding catalogue of products, the company offers a contract
synthesis service for molecular biology reagents. (Posted October
2000; updated August 2002.)
|
|
http://www.linktech.co.uk/
|
|
|
|
Louisiana Alliance for Biotechnology
(LAB)
|
|
LAB is dedicated to enhancing biotechnology research and business
development in the State of Louisiana. The goals set for LAB in order to
accomplish this mission are to facilitate: the development of an interactive
consortium of university and private sector researchers in molecular biology
and biotechnology; the transfer of scientific advances into the private
sector; enhancement of the university academic environment and community
quality of life through economic development associated with increased
private sector research and development; development and funding of research
to improve and expand Louisiana’s agriculture and industry; coordination
of state, federal, academic and business sector efforts to improve economic
conditions within the state through economic development in the
biotechnology sector. (Posted September 2000.)
|
|
http://www.labiotech.org/
|
|
|
|
LumaCareTM Biotechnology
|
|
LumaCareTM is a scientific company developing instrumentation
products in the field of biotechnology. The company has developed a
specialized noncoherent light source for the field of photodynamic therapy
(PDT) and for universal use with new Biotech pharmaceuticals (such as
Photofrin). Photodynamic therapy is a safe, non-invasive treatment for
numerous diseases, including psoriasis and other dermatological afflictions.
(Posted October 2000.)
|
|
http://www.lumacare.com/
|
|
|
|
Lynx Therapeutics, Inc.
|
|
Lynx applies its genomics, genetics, and proteomics
technologies to accelerate the pace, broaden the scale, enhance the quality,
and lessen the cost of the discovery and development efforts of customers in
the pharmaceutical and agricultural biotechnology industries. Lynx
has developed, and continues to develop, unique, proprietary processes aimed
at handling and analyzing, simultaneously, very large numbers of DNA
molecules or fragments in complex biological samples. At the core of these
processes is Lynx’s Megaclone™ technology. This is a micro-bead
technology that allows both the simultaneous collection of millions of
clones on as many micro-beads, and subsequent simultaneous manipulation or
analyses of these clones. Applications include the physical extraction of
genes (whether known or unknown) that are differentially expressed between
samples (Megasort™ technology), the characterization of gene expression
within a sample by Massively Parallel Signature Sequencing (MPSS®)
technology, and a novel, highly efficient means for genotyping very large
numbers of genetic markers or single nucleotide polymorphisms (SNPs),
simultaneously, against large populations of genomes (Megatype™
technology).
(Posted October 2000.)
|
|
http://www.lynxgen.com/
|
|
|
|
Mendel Biotechnology
|
|
Mendel is a pioneer in the application of functional genomics to the study
of plant genes. Mendel's business objective is to discover and characterize
the function of important plant genes and to develop and commercialize
high-margin products based on these discoveries. These products will benefit
customers in agriculture, healthcare, specialty ingredient, and consumer
product markets.
(Posted October 2000.)
|
|
http://www.mendelbio.com/
|
|
|
|
Michigan Biotechnology Association
(MBA)
|
|
The MBA, a not-for-profit membership association, was launched to increase
the understanding of the benefits of biotechnology and to support the growth
of bio-based businesses in Michigan. The development of infrastructure to
assist in the growth of biotechnology businesses is the primary goal of MBA.
MBA also disseminates information of interest to it's members. Its members
include companies, universities, research institutes and individuals who
are, or would like to become, involved in biotechnology.
(Posted September 2000.)
|
|
http://www.michbio.org/
|
|
|
|
Micrologix Biotech Inc.
|
|
Micrologix Biotech is a public biopharmaceutical company focusing on the
discovery, development and commercialization of innovative drugs to treat
life-threatening diseases. Our drug candidates are based on the development
of improved derivatives of naturally occurring peptide compounds found in
the defense systems of virtually all life forms. These powerful proprietary
compounds are remarkably effective at killing the multidrug-resistant
microbes responsible for the most clinically important infectious diseases. (Posted
October 2000.)
|
|
http://www.mbiotech.com/
|
|
|
|
National Biotechnology Information Facility
|
The National Biotechnology Information Facility
(NBIF) provides a single-point access to a vast store of
widely distributed biotechnology data including approximately 7,000 links to biotechnology resources.
The NBIF encourages information sharing between researchers in Academia, Industry, Government,
and the Department of Defense, promotes biotechnology in Historically Black Colleges and Universities
and Minority Institutions (HBCU/MIs), and provides training in biotechnology. The NBIF is also active
in developing new sources and types of biotechnology databases. (Posted
January 28, 2000.)
|
| http://www.nbif.org |
|
|
|
National Center for Biotechnology
Information (NCBI)
|
|
NCBI, a national resource for molecular biology information, creates public
databases, conducts research in computational biology, develops software
tools for analyzing genome data, and disseminates biomedical information,
all for the better understanding of molecular processes affecting human
health and disease. (Posted
October 2000.)
|
|
http://www.ncbi.nlm.nih.gov/
|
|
|
|
Nature Biotechnology Directory
|
|
The Nature Biotechnology Directory is a global information resource listing
over 9,000 organizations, product and service providers in the biotechnology
industry. Entries display details
about each organization, including organization name, address, telephone and
fax number, e-mail and web addresses. (Posted
October 2000.)
|
|
http://guide.nature.com/
|
|
|
|
Neugenesis Corporation
|
|
Neugenesis Corporation is a biotechnology company focused on generating
better biotherapeutics cost-effectively. To this end, Neugenesis has
developed technology that has substantial value in discovering, improving,
and producing complex proteins, especially heteromeric proteins. The
company's work with the filamentous fungus Neurospora crassa has
resulted in significant advances in two important areas of biotechnology
research, recombinant protein production and combinatorial biology. (Posted
October 2000.)
|
|
http://www.neugenesis.com/
|
|
|
|
New Zealand Biotechnology
Association
|
|
The Association was established to improve knowledge of biotechnology in New
Zealand; to represent the interests of those concerned with biotechnology in
New Zealand; to provide a forum for interaction among the disciplines
involved in biotechnology; and to foster an environment conducive to the
growth of biotechnology-based industries in New Zealand.
(Posted September 2000.)
|
|
http://www.biotech.org.nz/
|
|
|
|
North Carolina Biotechnology Center
|
|
The Center's mission is to provide long-term economic benefit to North
Carolina through support of biotechnology research, development and
commercialization statewide. It works toward that mission by assisting
business, education, and science. The Center is active at all points in the
movement of biotechnology from ideas to marketable products. It works
with academic researchers, entrepreneurs and company scientists, educators,
governmental policy-makers and all other parties involved in building a
thriving biotechnology industry. (Posted September 2000.)
|
|
http://www.ncbiotech.org/
|
|
|
|
Northern Bioidentification
Service Ltd.
|
|
Northern Bioidentification Service Ltd. is a biotechnology company providing
DNA analysis techniques to fish and wildlife conservation managers. The
company works with animal conservation managers and researchers to protect
and improve natural stocks of fish and wildlife. Through the use of
high-quality DNA typing and population genetic analysis, the company aims to
provide powerful and cost-effective tools used in conservation management.
(Posted October 2000.)
|
|
http://www.mts.net/~northern/
|
|
|
|
NRC Biotechnology Research Institute
|
|
BRI is located in Montréal, Canada, and maintains advanced facilities to
carry out collaborative research projects in molecular biology and
biochemical engineering, including: radiocrystallography equipment, an ion
spray mass spectrometer, NMR spectrometers, computer-assisted molecular
design, confocal light scanning microscopy system, analytical chemistry
laboratory (for the environmental sector), a 1,500 m² bioprocess facility
with fermenters ranging in size from 3.5 L to 1,500 L, and 350 m² of clean
rooms for separation and purification (class 10,000 and 100,000). BRI
concentrates its resources on collaborative projects with Canadian industry,
particularly companies working in the pharmaceutical and resource sectors.
(Posted September 2000.)
|
|
http://www.bri.nrc.ca/
|
|
|
|
NRC Plant Biotechnology Institute
|
|
The mission of the Plant Biotechnology Institute is to perform, assist and
promote strategic research in plant biotechnology, to improve and diversify
Canadian industry, and to strengthen Canada’s competitive position in the
global economy by fostering an entrepreneurial culture. The Institute
performs strategic research in key areas of plant biotechnology while
maintaining a world-class research calibre; ensures industrial relevance of
its research programs; nurtures innovation through efficient transfer of new
biotechnologies and their products to commercialization; provides
infrastructure and expertise; informs and transfers discoveries in plant
biotechnology to all interested parties in Canada; and trains and develops
highly qualified personnel in selected areas of plant biotechnology. (Posted
September 2000.)
|
|
http://www.pbi.nrc.ca/
|
|
|
|
Onyvax Limited
|
|
Onyvax is an early-stage biotechnology company focused
on the development of cancer therapies that employ the selectivity and power
of the immune system to seek and destroy tumor cells. (Posted
October 2000.)
|
|
http://www.onyvax.com/
|
|
|
|
Osmetech
|
|
Osmetech is dedicated to the rapid and inexpensive detection of
micro-organisms such as infectious bacteria, fungi and moulds through the
application of multi-sensor array technology. (Posted
September 2000.)
|
|
http://www.aromascan.com/
|
|
|
|
Pew Initiative on Food and
Biotechnology
|
|
Established to be an independent and objective source of credible
information on agricultural biotechnology for the public, media and
policymakers, the Pew Initiative on Food and Biotechnology is funded through
a grant from The Pew Charitable Trusts to
the University of Richmond. The
Initiative advocates neither for, nor against, agricultural biotechnology
but instead is committed to providing information and encouraging debate and
dialogue so that consumers and policymakers can make their own informed
decisions.
(Posted October 2001.)
|
|
http://pewagbiotech.org/
|
|
|
|
Phytera, Inc.
|
|
Phytera, Inc. is an international biotechnology
company that applies the genetic and chemical diversity of natural species
to the discovery of new pharmaceutical, agricultural and other products.
Phytera has developed proprietary cell culture technologies for plant
species (ExPAND®) and marine microbes (µMARINE®)
that provide the Company with unique and greatly expanded access to the
genetic and chemical diversity of each species. To date, the Company has
assembled the largest library of plant cells in culture in the world and
also has an extensive library of marine microbial cultures. The ExPAND® and
µMARINE® technologies involve extensive manipulation of the cell cultures
to simulate many different environments. This combinatorial biology approach
turns on silent genes in the cultured cells and results in the expression of
greatly expanded chemical diversity. Phytera captures the genes and expanded
chemical diversity in its proprietary databases and libraries.
(Posted October 2000.)
|
|
http://www.phytera.com/
|
|
|
|
Princeton
Separations, Inc. (PSI)
|
|
PSI is a privately-owned, manufacturing-based biotechnology company
specializing in molecular separations. PSI manufactures various successful
products including: CENTRI·SEPTM spin columns, used in DNA
sequencing; PANAGEL® high-resolution electrophoresis systems,
used in analysis of proteins in human body fluids; CENTRI·SPINTM
columns, used in the purification of a variety of biomolecules (DNA,
proteins and carbohydrates) and PSI CLONE Plasmid Prep kit for
purification of plasmid DNA. (Posted October 2000.)
|
|
http://www.prinsep.com/
|
|
|
|
Progen Industries Limited
|
|
Progen Industries Limited is an Australian biotechnology company
specialising in the manufacture and supply of molecular biology reagents and
kits. Involved in pharmaceutical research and development, Progen recently
commenced its second Phase I clinical trial with its lead compound (PI-88)
for treatment of solid tumors. Progen is also involved in the development of
a number of other potential biopharmaceuticals. (Posted
October 2000.)
|
|
http://progen.com.au/
|
|
|
|
Recombinant Capital (ReCap)
|
|
The purpose of the ReCap website is to provide a resource to biotechnology
executives who are involved with financing, business development, licensing
and other strategic planning essential to the development and
commercialization of biotechnology, pharmaceuticals, diagnostics and medical
devices. (Posted October 2000.)
|
|
http://www.recap.com/
|
|
|
|
Reliable Biopharmaceutical
Corporation
|
|
Reliable Biopharmaceutical Corporation is a manufacturer of active
pharmaceutical ingredients, nucleic acids, biochemicals, and enzymes for the
pharmaceutical and biotechnology industries. The company isolates
deoxynucleosides and deoxynucleotides from Salmon DNA. The company's
nucleotides and nucleosides are of the highest purity available. They also
synthesize DMT protected 2'O methyl ribonucleosides and deoxynucleosides.
After these protected deoxy and ribo nucleosides are converted to
phosphoramidite derivatives, they can be incorporated into the new antisense
therapeutic and diagnostic compounds. (Posted
October 2000.)
|
|
http://www.reliablebiopharm.com/
|
|
|
|
Reticula Bio
|
|
Reticula Bio is a research and development consortium
that specializes in advanced technology and biopharmaceutical research and
development. The company's two divisions reflect its broad research
interests. The biosciences division investigates and develops novel
pharmaceutical, biotechnology and agricultural products and the advanced
technologies division specializes in immersive technology, robotics and
computing applications. (Posted October 2000.)
|
|
http://www.reticulabio.com/
|
|
|
|
Q-One Biotech
|
|
Q-One Biotech is a world-renowned authority in providing specialist safety
testing and process validation services, cGMP contract manufacturing of cell
banks, vaccines and gene therapy products to the biopharmaceutical industry.
Q-One operates in full compliance with GMP and GLP standards. (Posted
October 2000.)
|
|
http://www.q-one.com/
|
|
|
|
Quebec Bio-Industries Association
|
|
The Quebec Bio-Industries Association, which counts close to 200
innovative companies as members, is committed to supporting the growth and
vitality of Quebec’s biotechnology companies. The QBA's member companies
are active in research and manufacturing of therapeutic and diagnostic
products, vaccines and biological products of human and animal health; in
research and primary production in the areas of agriculture, aquaculture,
secondary processing and beverages; and in research and production in the
waste treatment, biomass processing, environmental rehabilitation, mining
and peat bog sectors. (Posted
September 2000.)
|
|
http://www.aqb.qc.ca/
|
|
|
|
Quebec Biotechnology Innovation
Centre (QBIC)
|
|
QBIC is the first business incubator specializing in biotechnology to emerge
in Québec. This non-profit organization offers researcher-entrepreneurs in
Québec and elsewhere, an environment conducive to their research and
development activities, while promoting the acquisition and transfer of
management skills. The goal of the QBIC is to promote the development of
young innovative companies working in the field of biotechnology applied to
the health, environment, agri-food and forestry sectors. To do this, the
QBIC makes specialized equipment infrastructures available to these
companies and offers them business services and counseling in line with
their needs. By supporting the start-up of companies in this new economic
sector, the QBIC and its partners are contributing to job creation in
Québec and the emergence of a generation of entrepreneurs in the
biotechnology sector. (Posted September 2000.)
|
|
http://www.cqib.org/indexe.htm
|
|
|
|
Seikagaku Corporation
|
|
Seikagaku Corporation has evolved into a major contributor in the biotech
industry specializing in pharmaceutical products such as ARTZ®,
research biological and diagnostics such as Endospecy®, as well
as pursuing R&D efforts in developing technologies based on
Glycoconjugates. (Posted October 2000.)
|
|
http://www.seikagaku.com/
|
|
|
|
Senetek PLC
|
|
Senetek PLC is a science-driven biotechnology company that develops,
manufactures and markets proprietary solutions for aging-related healthcare
problems. Senetek business divisions include three separate, distinct and
significant opportunities in biopharmaceuticals, autoinjectable drug
delivery systems, and cosmeceuticals. (Posted October
2000.)
|
|
http://www.senetekplc.com/
|
|
|
|
Sunnyday
Environmental & Bio-Tech Services Ltd.
|
|
While Sunnyday has the staff, expertise and experience to handle a wide
variety of projects, their specialty is the design
and construction of complete utility systems for pharmaceutical research
labs and cGMP pilot plant facilities which
demands specific knowledge with regard to cGMP and FDA requirements. The
ultimate goal is not only high performance, but also validation of utility
systems. All the necessary equipment, instrumentation and control, material
and labor are supplied to meet the needs of the company's projects. For pure
steam/WFI systems the company performs the orbital stainless steel welding
using computer controlled automatic equipment to secure consistent quality. (Posted
October 2000.)
|
|
http://www.sunnyday-biotech.com/index.html
|
|
|
|
Techniclone Corporation
|
|
Techniclone Corporation is a biotechnology company focused on the research,
development and commercialization of novel cancer therapeutics in two
principal areas: 1) direct tumor targeting agents for the treatment of
refractory malignant lymphomas and 2) collateral indirect targeting agents
for the treatment of solid tumors. (Posted
October 2000.)
|
|
http://www.techniclone.com/
|
|
|
|
Technology
to Feed the World
U.S. National Academy of
Sciences (NAS) Web Extra
|
An international working
group of seven science academies--Royal Society of London, the U.S |